Predictive Oncology Reports Third Quarter Financial Results
EAGAN, Minn., Nov. 10, 2022 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ:POAI) today announced the financial results for its third quarter ended September 30, 2022, which continue to reflect revenue growth and increased gross profit margin as compared to prior year periods. Highlights from the quarter include:
Related news for (POAI)
- Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens
- 24/7 Market News Snapshot 29 September, 2025 – Predictive Oncology Inc. Common Stock (NASDAQ:POAI)
- Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
- UPDATE – Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
- 24/7 Market News Snapshot 22 May, 2025 – Predictive Oncology Inc. Common Stock (NASDAQ:POAI)